LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
This Quarter Return
+0.91%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$2.33B
AUM Growth
+$2.33B
(+5.1%)
Cap. Flow
+$13M
Cap. Flow
% of AUM
0.56%
Top 10 Holdings %
Top 10 Hldgs %
45.1%
Holding
496
New
201
Increased
33
Reduced
55
Closed
102
Top Buys
| 1 |
T-Mobile US
TMUS
|
$123M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$92.8M |
| 3 |
Microsoft
MSFT
|
$78.9M |
| 4 |
Pliant Therapeutics
PLRX
|
$57.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
$53.9M |
Top Sells
| 1 |
Viatris
VTRS
|
$128M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
$60.4M |
| 3 |
Comcast
CMCSA
|
$56.4M |
| 4 |
Emerson Electric
EMR
|
$55M |
| 5 |
Home Depot
HD
|
$54.8M |
Sector Composition
| 1 | Healthcare | 41.67% |
| 2 | Technology | 19.29% |
| 3 | Communication Services | 12.94% |
| 4 | Utilities | 10.55% |
| 5 | Industrials | 3.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Aldeyra Therapeutics
ALDX
$350M
| $8.4M | 0.05% |
1,001,377
+44,477
| +5% | +$373K |
|
52
PNC Financial Services
PNC
$80.7B
| $8.15M | 0.05% |
64,704
+52,141
| +415% | +$6.57M |
|
53
Pyxis Oncology
PYXS
$91.2M
| $8.12M | 0.05% |
3,170,803
| – | – |
|
54
Target
TGT
$42B
| $7.49M | 0.04% |
56,751
+53,152
| +1,477% | +$7.01M |
|
|
ICVX
55
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $7.37M | 0.04% |
742,354
| – | – |
|
56
Altimmune
ALT
$325M
| $6.49M | 0.04% |
1,839,604
-1,661,726
| -47% | -$5.87M |
|
57
PepGen
PEPG
$39M
| $5.94M | 0.03% |
664,516
| – | – |
|
58
Broadcom
AVGO
$1.42T
| $5.87M | 0.03% |
+6,772
| New | +$5.87M |
|
59
Acumen Pharmaceuticals
ABOS
$84.2M
| $5.8M | 0.03% |
1,206,548
| – | – |
|
60
Cummins
CMI
$54B
| $5.49M | 0.03% |
22,396
-3,493
| -13% | -$856K |
|
61
Netflix
NFLX
$521B
| $5.47M | 0.03% |
+12,419
| New | +$5.47M |
|
62
lululemon athletica
LULU
$23.8B
| $5.36M | 0.03% |
14,174
+1,107
| +8% | +$419K |
|
63
Thermo Fisher Scientific
TMO
$183B
| $5.31M | 0.03% |
+10,169
| New | +$5.31M |
|
64
Starbucks
SBUX
$99.2B
| $5.14M | 0.03% |
+51,856
| New | +$5.14M |
|
65
Solid Biosciences
SLDB
$448M
| $4.86M | 0.03% |
928,169
| – | – |
|
66
Rallybio
RLYB
$24.1M
| $4.43M | 0.02% |
783,391
| – | – |
|
67
AnaptysBio
ANAB
$630M
| $4.25M | 0.02% |
209,002
-54,206
| -21% | -$1.1M |
|
68
Scholar Rock
SRRK
$3.3B
| $4.05M | 0.02% |
537,798
-15,902
| -3% | -$120K |
|
69
Synopsys
SNPS
$110B
| $3.9M | 0.02% |
+8,968
| New | +$3.9M |
|
70
Cadence Design Systems
CDNS
$94.6B
| $3.83M | 0.02% |
+16,335
| New | +$3.83M |
|
71
UroGen Pharma
URGN
$896M
| $3.82M | 0.02% |
369,105
-11,495
| -3% | -$119K |
|
72
ServiceNow
NOW
$191B
| $3.74M | 0.02% |
+6,658
| New | +$3.74M |
|
|
VMW
73
DELISTED
VMware, Inc
VMW
| $3.66M | 0.02% |
25,497
-2,454
| -9% | -$353K |
|
|
AUTL
74
Autolus Therapeutics
AUTL
$383M
| $3.57M | 0.02% |
1,500,000
| – | – |
|
|
IMA
75
ImageneBio, Inc. Common Stock
IMA
$153M
| $3.4M | 0.02% |
517,563
-11,437
| -2% | -$75K |
|